je.st
news
Tag: therapies
Open Source Joins Efforts to Create Gene Therapies for Rare Diseases
2021-04-26 14:00:00| TechNewsWorld
Some 400 million patients worldwide are affected by more than 7,000 rare diseases; yet treatments for rare genetic diseases remain an underserved area. The father of a boy born with a rare disease created the RareCamp project, and the OpenTreatments Foundation, to enable patients to create gene therapies for rare genetic diseases; then work with their doctors and nonprofits to develop drugs.
Tags: create
open
source
open source
Pirbright studies show pigs ideal for assessing flu antibody therapies
2020-07-02 15:50:00| National Hog Farmer
Pigs provide an intermediate step between trials in smaller animals and humans and could provide more accurate assessments of antibody therapies.
Tags: show
studies
ideal
assessing
There's a major roadblock to one of the most talked about new cancer therapies
2016-03-14 21:21:47| Biotech - Topix.net
When it comes to treating difficult diseases like cancer, researchers have been leaning more and more toward the concept of precision medicine. It means finding a unique course of treatment that is tailored toward a cancer tumor's particular characteristics.
Premarket Biotech Digest: Breast Cancer Therapies, Anavex's Milestone, Praluent EU Approval
2015-09-29 16:11:27| Biotech - Topix.net
Targeted therapies in breast cancer are the latest developments in this area of therapeutics. Although these therapies sometimes cause serious side effects, for example, damage to heart muscles in some HER2 inhibitors, they offer a non-surgical option for treating breast cancer.
Tags: approval
cancer
breast
digest
Abbott to Broaden Foundation in Structural Heart Therapies with Two Mitral Valve Transactions
2015-08-03 12:31:10| Industrial Newsroom - All News for Today
Acquisition of Tendyne Holdings, Inc. to Expand Abbott's Mitral Valve Therapies In Separate Transaction, Abbott Has Provided Capital and Secured an Option to Purchase Cephea Valve Technologies ABBOTT PARK, Ill. - Abbott (NYSE: ABT) announced today that it has entered into an agreement to purchase Tendyne...
Tags: heart
foundation
transactions
structural